The Ten Worst Drug Recalls In The History Of The FDA

1) Fenfluramine/phentermine (Fen-Phen)

  • Wyeth-Ayerst Laboratories
  • Recalled: 1997 (after 24 years on the market) No.Of Views: 1239 Read More

Cleaning Validation - Impact on GMP

The topic cleaning validation gained new importan..
No.Of Views: 1147 Read More

Modifying Medicines May Alter Original Quality Characteristics-Requirement for a comprehensive Stability Testing Program

Stability studies are an essential component of pharmaceutical development, allowing evaluation ..
No.Of Views: 1521 Read More


Bioanalytical methods are..
No.Of Views: 975 Read More

Testing of new drugs when the "metabolites are either identified only in humans or are present at disproportionately higher levels in humans than in any of the animal species used during standard nonclinical toxicology testing".  It should be of interest to many in the pharma and CRO world.

Aligned ..
No.Of Views: 3487 Read More

The ICH guideline Q3C "Impurities: Guideline for residual solvents" contains specifications for several organic solvents that are used in the synthesis of active pharmaceutical ingredients, intermediate products or raw materials. Due to their, in some cases, high toxic potential, appropriate limit values in the fi..
No.Of Views: 1138 Read More

On the 2nd Oct 2017, the US Food and Drug Administration (FDA) organized a two-day meeting on modernizing generic drug development and released two new draft guidance documents on complex generic drugs – an area where increasing competition can be difficult.

FDA Commissioner Scott Gottlieb spoke at the meeti..
No.Of Views: 1081 Read More

4th October 2017

The US Food and Drug Administration (FDA) this week released a guidance that is part of a series from the International Council of Harmonisation (ICH) on the format for preparing the Common Technical Document (CTD) for applications submitted to FDA.

"A common format..
No.Of Views: 1533 Read More

The U.S. Food and Drug Administration today launched a new user-friendly search tool that improves access to data on adverse events associated with drug and biologic products through the FDA's Adverse Event Reporting System (FAERS). The tool is designed to make it easier for consumers, providers, and researchers to acce..
No.Of Views: 1153 Read More

The USFDA has determined the agency will recognize eight European drug regulatory authorities as capable of conducting inspections of manufacturing facilities that meet FDA requirements. The eight regulatory authorities found to be capable are those located in: Austria, Croatia, France, Italy, Malta, Spain, Sweden and the U..
No.Of Views: 1312 Read More

Latest News

QIP 2017 at Birla Institute of Technology, Ranchi, Jharkhand

The AICTE sponsored QIP 2017 on “Rational Approach to Drug Development” was organized during June 02-15, 2017 und..

Faculty Training & Development Workshop on HPLC at VNIPS, Vizag

We conducted faculty training & development workshop on HPLC Method Development & Validation at Viswanadha Institute ..

QIP 2015 at Birla Institute of Technology, Ranchi, Jharkhand

The AICTE sponsored QIP 2015 on “Innovative Drug Discovery Approaches & Emerging Trends in Neuropharmacology”..

Certificate Program on HPLC Instrumentation & Quality Control Techniques

1 Month Certificate Oriented Intensive Program.

The course covers all the concepts of chromatograp..

Recent Posts